SCHEMBL8569672

SCHEMBL8569672

CCN(CC)C(=O)C(C)(C)c1ccc2[nH]c(-c3cc(C)cc(C)c3)c(CCN)c2c1

nearest known ligand 0.66

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GNRHR P30968 12/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14424655 0.88 GNRHR (0.69) GNRHR
SCHEMBL6976457 0.85 GNRHR (0.49) GNRHR
SCHEMBL6804909 0.85 GNRHR (0.50) GNRHR
SCHEMBL7855390 0.83 GNRHR (0.57) GNRHR
SCHEMBL7855392 0.83 GNRHR (0.57) GNRHR
SCHEMBL5753476 0.82 GNRHR (0.69) GNRHR
SCHEMBL14424652 0.82 GNRHR (0.61) GNRHR
SCHEMBL14438150 0.82 GNRHR (0.57) GNRHR
SCHEMBL5789796 0.81 GNRHR (0.81) GNRHR
SCHEMBL14438214 0.81 GNRHR (0.67) GNRHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7449489-B2 Indolylalkylamino-methylidenecarbamate derivatives useful as GnRH antagonists ASTRAZENECA AB (SE) 2008-11-11 US disclosed
US-7256188-B2 3-aminoalkyl-2-aryl-indole derivatives and their use as GnRH antagonists ASTRAZENECA AB (SE) 2007-08-14 US disclosed
US-7256188-B2 3-aminoalkyl-2-aryl-indole derivatives and their use as GnRH antagonists ASTRAZENECA AB (SE) 2007-08-14 US disclosed
US-5849764-A Antagonists of gonadotropin releasing hormone MERCK & CO., INC. (US) 1998-12-15 US disclosed
EP-0871624-A1 ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE Merck & Co., Inc. (US) 1998-10-21 EP disclosed
WO-1997021703-A1 ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE MERCK & CO., INC. (US) 1997-06-19 WO disclosed